Recurrent priapism related to oxaliplatin infusion.
Adenis
Antoine
A
Mailliez
Audrey
A
Rigot
Jean-Marc
JM
Gamelin
Laurence
L
Vanhuyse
Marie
M
Gamelin
Erick
E
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D017610:Calcium Compounds / Q000008:administration & dosage; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D017616:Magnesium Compounds / Q000008:administration & dosage; D008297:Male; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D000077150:Oxaliplatin; D011317:Priapism / Q000139:chemically induced* / Q000517:prevention & control
D000970:Antineoplastic Agents; D017610:Calcium Compounds; D017616:Magnesium Compounds; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D002955:Leucovorin; D005472:Fluorouracil